104 related articles for article (PubMed ID: 27982417)
41. Concurrence of e1a2 and e19a2 BCR-ABL1 Fusion Transcripts in a Typical Case of Chronic Myeloid Leukemia.
Lee J; Kim DS; Lee HS; Choi SI; Cho YG
Ann Lab Med; 2017 Jan; 37(1):74-76. PubMed ID: 27834071
[No Abstract] [Full Text] [Related]
42. High reliability and sensitivity of the BCR/ABL1 D-FISH test for the detection of BCR/ABL rearrangements.
Pelz AF; Kröning H; Franke A; Wieacker P; Stumm M
Ann Hematol; 2002 Mar; 81(3):147-53. PubMed ID: 11904740
[TBL] [Abstract][Full Text] [Related]
43. Atypical fluorescence in situ hybridisation pattern in chronic myeloid leukaemia due to cryptic insertion of BCR at 9q34.
Wan TS; Ma SK; Li CK; Chan LC
Leukemia; 2004 Jan; 18(1):161-2; author reply 162-4. PubMed ID: 14603334
[No Abstract] [Full Text] [Related]
44. A Ph-negative chronic myeloid leukemia with a complex BCR/ABL rearrangement and a t(6;9)(p21;q34.1).
Todorić-Zivanović B; Marisavljević D; Surace C; Cemerikić V; Marković O; Krtolica K; Tatomirović Z; Cikota B; Magić Z; Rocchi M
Cancer Genet Cytogenet; 2006 Apr; 166(2):180-5. PubMed ID: 16631477
[TBL] [Abstract][Full Text] [Related]
45. Emergence of
Kim H; Kim IS; Kim H
Ann Lab Med; 2023 Jul; 43(4):386-388. PubMed ID: 36843408
[No Abstract] [Full Text] [Related]
46. BCR-ABL1-like acute lymphoblastic leukaemia: From bench to bedside.
Boer JM; den Boer ML
Eur J Cancer; 2017 Sep; 82():203-218. PubMed ID: 28709134
[TBL] [Abstract][Full Text] [Related]
47. [Role of molecular screening for common fusion genes in the diagnosis and classification of leukemia].
Zhu YL; Zhang Y; Zhu P; Yang Y; Du JW; Liu J
Beijing Da Xue Xue Bao Yi Xue Ban; 2005 Jun; 37(3):236-9. PubMed ID: 15968309
[TBL] [Abstract][Full Text] [Related]
48. Chronic myeloid leukemia presenting with absence of basophils and marked dyspoiesis.
Anand M; Kumar R; Kumar L; Barge S; Singh S
Indian J Cancer; 2003; 40(4):144-7. PubMed ID: 14716111
[TBL] [Abstract][Full Text] [Related]
49. International reporting scale of BCR-ABL1 fusion transcript in chronic myeloid leukemia: first report from India.
Balasubramanian P; Chendamarai E; Markose P; Fletcher L; Branford S; George B; Mathews V; Chandy M; Srivastava A
Acta Haematol; 2012; 127(3):135-42. PubMed ID: 22249155
[TBL] [Abstract][Full Text] [Related]
50. Therapy-related acute leukemia with mixed phenotype and t(9;22)(q32;q11.2): a case report and review of the literature.
Cho JH; Hur M; Moon HW; Yun YM; Ko YS; Kim WS; Lee MH
Hum Pathol; 2012 Apr; 43(4):605-9. PubMed ID: 22036054
[TBL] [Abstract][Full Text] [Related]
51. Impact of the BCR-ABL1 fusion transcripts on different responses to Imatinib and disease recurrence in Iranian patients with Chronic Myeloid Leukemia.
Rostami G; Hamid M; Jalaeikhoo H
Gene; 2017 Sep; 627():202-206. PubMed ID: 28627443
[TBL] [Abstract][Full Text] [Related]
52. BCR-ABL1 transcript types showed distinct laboratory characteristics in patients with chronic myeloid leukemia.
Vasconcelos AP; Azevedo IF; Melo FCBC; Neves WB; Azevedo ACAC; Melo RAM
Genet Mol Res; 2017 Apr; 16(2):. PubMed ID: 28437552
[TBL] [Abstract][Full Text] [Related]
53. Amplification of BCR-ABL and t(3;21) in a patient with blast crisis of chronic myelogenous leukemia.
Phan CL; Megat Baharuddin PJ; Chin LP; Zakaria Z; Yegappan S; Sathar J; Tan SM; Purushothaman V; Chang KM
Cancer Genet Cytogenet; 2008 Jan; 180(1):60-4. PubMed ID: 18068536
[TBL] [Abstract][Full Text] [Related]
54. A masked BCR/ABL rearrangement in a case of chronic myeloid leukemia with translocation t(3;9)(p14;q34).
Bennour A; Sennana H; Laatiri MA; Khelif A; Saad A
Cancer Genet Cytogenet; 2008 Feb; 181(1):72-4. PubMed ID: 18262060
[No Abstract] [Full Text] [Related]
55. Longitudinal clonal architecture of acute myeloid leukemia with
Gallego Hernanz MP; Sorel N; Bouyer S; Desmier D; Chollet M; Maillard N; Brizard F; Moya N; Diaz JMT; Leleu X; Chomel JC
Leuk Lymphoma; 2020 Jul; 61(7):1709-1713. PubMed ID: 32077355
[No Abstract] [Full Text] [Related]
56. Detection of CALR Mutation in Clonal and Nonclonal Hematologic Diseases Using Fragment Analysis and Next-Generation Sequencing.
Gardner JA; Peterson JD; Turner SA; Soares BL; Lancor CR; Dos Santos LL; Kaur P; Ornstein DL; Tsongalis GJ; de Abreu FB
Am J Clin Pathol; 2016 Oct; 146(4):448-55. PubMed ID: 27686171
[TBL] [Abstract][Full Text] [Related]
57. t(9;11)(p22;p15) [NUP98/PSIP1] is a poor prognostic marker associated with de novo acute myeloid leukaemia expressing both mature and immature surface antigens.
Lundin C; Horvat A; Karlsson K; Olofsson T; Paulsson K; Johansson B
Leuk Res; 2011 Jun; 35(6):e75-6. PubMed ID: 21168209
[No Abstract] [Full Text] [Related]
58. [Mutations in the BCR-ABL1 gene in a peruvian patient with acute lymphoblastic leukemia resistant to therapy].
Ortiz CA; Alvarez YP; Dongo-Pflucker KL; Valdivia E; Mendoza Fernández J; Dávila S; Mora-Alférez P
Rev Fac Cien Med Univ Nac Cordoba; 2017; 74(2):162-166. PubMed ID: 28657534
[TBL] [Abstract][Full Text] [Related]
59. CD66c expression in B-cell acute lymphoblastic leukemia: strength and weakness.
Guillaume N; Penther D; Vaida I; Gruson B; Harrivel V; Claisse JF; Capiod JC; Lefrere JJ; Damaj G
Int J Lab Hematol; 2011 Feb; 33(1):92-6. PubMed ID: 20666852
[TBL] [Abstract][Full Text] [Related]
60. BCR-ABL1 in leukemia: disguise master outplays riding shotgun.
Rana A; Ali GM; Ali S; Khan A; Mansoor S; Malik S; Farooqi AA
J Cancer Res Ther; 2013; 9(1):6-10. PubMed ID: 23575066
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
